Korea
AIRS Medical Raises $20M in Series B Funding
SEOUL, South Korea, Aug. 19, 2022 /PRNewswire/ -- AIRS Medical, a healthcare startup based inSouth Korea and a member of the Born2Global Centre, recently announced that it has raised approximately$20M in Series B funding. The round of Series B funding welcomed new investors Q Capital Partners and...
2022-08-19 21:00
3069
Global Sae-A Group Completes Construction of the Second Spinning Mill in Costa Rica
* This is the Korean company's second factory in Costa Rica, where construction of its third factory has already begun and is expected to go into operation in 2024. * The company will create 200 more jobs across multiple areas for people with different educational levels, from primary to high...
2022-08-19 21:00
4146
J INTS BIO successfully held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR TKI (JIN-A02) in Vienna, Austria during WCLC
SEOUL, South Korea, Aug. 19, 2022 /PRNewswire/ -- J INTS BIO announced that it held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR-TKI 'JIN-A02' on the sideline of the 2022 IASLC World Conference on Lung Cancer held inVienna, Austria, on 7th August. This follo...
2022-08-19 16:00
1462
Amorepacific Develops World's First Chip-less Wireless Electronic Skin Enabled by Semiconductors
SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- Amorepacific, a South Korean beauty and cosmetics conglomerate, in collaboration with ProfessorKim Jeehwan at MIT, has developed the world's first chip-less wireless wearable electronic skin (e-skin) that is sweatproof and can continuously monitor ...
2022-08-19 02:00
2607
CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma
ORINDA, Calif. and SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- CG Pharmaceuticals, Inc. announced the first patient dosed with the ivaltinostat and capecitabine combination therapy for the Phase1b/2 pancreatic adenocarcinoma (PDAC) maintenance study. Commencement of treatment for the first...
2022-08-18 21:00
1961
Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery
Veteran biotech and pharmaceutical executive will help company increase its
growth and international impact
SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- Standigm Inc.
2022-08-18 20:30
2568
SwatchOn Launches a Digital Twin 3D Fabric Library to Forge Fashion's Future.
Seoul, South Korea, Aug. 17, 2022 /PRNewswire/ -- Wholesale fashion fabric
aggregate SwatchOn has launched its sister service,VMOD 3D Library
2022-08-17 18:35
3330
RemoteMeeting Now Available on LG Smart TVs
LG webOS TV owners first to benefit from Rsupport's video-conferencing service, RemoteMeeting,on the big screen at home SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- Remote work, workcation, or hybrid work have become part of a mainstream, a paradigm shift also has begun in video conferencin...
2022-08-16 21:00
4495
STANDIGM WINS GOLD AND BRONZE STEVIE® AWARDS IN 2022 INTERNATIONAL BUSINESS AWARDS®
Winners to Be Celebrated During Event in London on 15 October
SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- Standigm
2022-08-16 20:30
3576
Kakao Entertainment to hold global K-Pop auditions, starting with applications in the U.S.
SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- Representing popular K-pop
artists such as Monsta X, IVE, and The Boyz, Kakao Entertainment is set to hold
a series of auditions around the world to discover next-generation K-pop
singers and idol groups.
2022-08-16 20:00
5422
J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' at the 2022 World Conference on Lung Cancer in Vienna, Austria (IASLC 2022 WCLC)
SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- J INTS BIO announced that the pre-clinical data of its novel, orally administered 4th generation EGFR TKI 'JIN-A02' was presented on the 8th of August, at the 2022 IASLC World Conference on Lung Cancer held inVienna, Austria, during the official s...
2022-08-16 13:35
2128
Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877
* BBT-877 is intended to explore its treatment efficacy in idiopathic pulmonary fibrosis patients in a Phase II trial expected to start in 2022 SEONGNAM, South Korea, Aug. 15, 2022 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing ...
2022-08-16 08:17
2682
Lunit Announces Financial Results for the First Half of 2022
* Consolidated revenue in the second quarter of 2022 increased by 190% compared to same prior-year period * Total revenue for H1 2022 amounted to KRW 5.48 billion, or 82.5% of the total revenue of last year SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ -- Lunit (KRX: 328130.KQ), a global pro...
2022-08-12 21:00
13474
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma.
SEOUL, South Korea, Aug. 11, 2022 /PRNewswire/ -- J INTS BIO announced that the pre-clinical data of its novel, orally administered 4th generation EGFR TKI 'JIN-A02' was presented at the 2022 IASLC World Conference on Lung Cancer in Vienna, Austria on 8th August, at the official session "Overcomin...
2022-08-12 10:13
2273
Panacell Biotech to conduct toxicity tests for NK cells, exosomes, and brown adipose-derived stem cells to treat patients with long COVID
SEOUL, South Korea, Aug. 10, 2022 /PRNewswire/ -- Panacell Biotech Co., Ltd.
said that NK cells, exosomes, and brown adipose-derived stem cells are
effective to treat patients with long COVID conditions, or post COVID-19
conditions, as well as those with terminal illness.
2022-08-10 22:00
3599
Bridge Biotherapeutics Presents Promising Interim Clinical Study Results from Phase 1 Study of BBT-176 at WCLC 2022
* The study confirmed preliminary efficacy and safety of BBT-176 along with its treatment responses in advanced NSCLC patients * A patient with the C797S triple mutation showed up to 53 percent reduction in EGFR mutant allelic change VIENNA and SEONGNAM, South Korea, Aug. 9, 2022 /PRNewswire/...
2022-08-10 11:43
2599
VIS BLANC participated in International Cosmetic Exhibitions in earnest
SEOUL, South Korea, Aug. 9, 2022 /PRNewswire/ -- ELKO Trading's brand 'VIS BLANC', which has been supplying famous overseas brands for 30 years, introduced a new product (2STEP MASK) that fits the brand concept through the International Cosmetics Expo held at COEX in Korea this year. VIS BLANC al...
2022-08-10 10:38
1933
iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform
* CRISPR/Cas system for bacteria that are not E. coli or Streptococcus pyogenes * Customized gene editing technology for unique modified-bacteriophages * To validate efficacy of SARS-CoV-2 mimotopes loaded PHAGERUS® platform BOSTON and SEOUL, South Korea, Aug. 9, 2022 /PRNewswire/ -- iNtRON ...
2022-08-10 09:00
2164
StradVision announces close of $88m Series C funding round
* ADAS industry leader StradVision announces the close of their $88m Series C
funding round by ZF, Aptiv, and other financial investors. SEOUL, South Korea,
Aug. 9, 2022 /PRNewswire/ -- StradVision
2022-08-09 23:00
3682
Bespin Global, named 'a Visionary' in 2022 Gartner® Magic Quadrant™ for Public Cloud IT Transformation Services
- Only 20 companies in the world are named in this category, after the establishment of the new market last year,Bespin Global has been recognized as 'a Visionary' this year - Bespin Global, recognized for its vision and execution - Bespin Global named on Gartner® Magic Quadrant™...
2022-08-05 21:00
5885
Week's Top Stories
Most Reposted
DayOne Appoints Nicolas Aguzin to Board of Directors, Strengthening Global Governance and Capital Markets Expertise
[Picked up by 281 media titles]
2026-05-29 15:50Pudu Robotics and Shenzhen CTID Co. Ltd Launch the World's First Full-Scenario Robot-Serviced Hotel Project
[Picked up by 275 media titles]
2026-06-01 18:00Creality 3D Successfully Listed in Hong Kong
[Picked up by 271 media titles]
2026-05-29 11:21
PHOTO & IMAGE SHANGHAI 2026 to Showcase AI Imaging, Content-Creation Technologies and Emerging Visual Trends This July
[Picked up by 269 media titles]
2026-05-29 17:36
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
[Picked up by 269 media titles]
2026-05-30 11:58
Most Read
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
2026-05-30 11:58
7952
AMTD's Successful Completion of Acquisition of The Ritz-Carlton, Perth, Valued at A$280 Million
2026-05-29 21:50
7425
Creality 3D Successfully Listed in Hong Kong
2026-05-29 11:21
6874
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
2026-05-29 22:00
6588